Clark Wang
About Clark Wang
Clark Wang is a Research Associate 2 with expertise in bioconjugation and assay development. He has a background in chemistry and has worked in various research and quality control roles across multiple organizations since 2013.
Work at Lumos Diagnostics
Clark Wang has been employed at Lumos Diagnostics as a Research Associate 2 since 2020. In this role, he has demonstrated proficiency in bioconjugation techniques applied to various nanoparticle surfaces. He has authored and presented reports on assay results and analysis for regulatory bodies, including the FDA in the United States and TGA in Australia. His work involves developing a phase-driven approach to assay development, which aids in the transition from feasibility studies to manufacturing processes.
Previous Experience in Biopharma and Research
Prior to his current position, Clark Wang worked at Ajinomoto Bio-Pharma Services as a QC Chemistry Associate 2 from 2019 to 2020 for 10 months in San Diego, CA. He also served as a Research Associate 2 at nanoComposix from 2018 to 2019 for one year. His earlier experience includes a role as a Research Assistant at The College of Wooster from 2016 to 2017 for 8 months, where he contributed to various research projects.
Educational Background in Chemistry
Clark Wang earned a Bachelor’s Degree in Chemistry from The College of Wooster, where he studied from 2014 to 2018. His education provided a strong foundation in chemical principles and research methodologies. During his time at the college, he also served as a Student Crew Leader from 2014 to 2018, gaining leadership experience while supporting various academic initiatives.
Volunteer Experience in Healthcare
Clark Wang volunteered at the Department of Veterans Affairs Healthcare System in Palo Alto from 2013 to 2014 for one year. This experience allowed him to gain insight into healthcare operations and patient care, contributing to his overall understanding of the biopharmaceutical field.
Skills in Assay Development and Safety Protocols
Clark Wang has developed a phase-driven approach to assay development, which facilitates the transition from initial feasibility to manufacturing transfer. He is experienced in handling infectious agents, including SARS-CoV-2, while adhering to proper personal protective equipment (PPE) and biosafety level (BSL) conditions, ensuring compliance with safety protocols in laboratory settings.